Back to Search
Start Over
Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants
- Source :
- The Lancet Diabetes & Endocrinology; January 2020, Vol. 8 Issue: 1 p36-49, 14p
- Publication Year :
- 2020
-
Abstract
- The benefits of LDL cholesterol-lowering treatment for the prevention of atherosclerotic cardiovascular disease are well established. However, the extent to which these effects differ by baseline LDL cholesterol, atherosclerotic cardiovascular disease risk, and the presence of comorbidities remains uncertain.
Details
- Language :
- English
- ISSN :
- 22138587 and 22138595
- Volume :
- 8
- Issue :
- 1
- Database :
- Supplemental Index
- Journal :
- The Lancet Diabetes & Endocrinology
- Publication Type :
- Periodical
- Accession number :
- ejs51812016
- Full Text :
- https://doi.org/10.1016/S2213-8587(19)30388-2